Last week, the U.S. District Court for the Eastern District of Tennessee denied a motion to dismiss claims brought by the United States against Murphy Medical Center Inc. d/b/a Erlanger Western Carolina Hospital and Chattanooga-Hamilton County Hospital Authority d/b/a Erlanger Health System (collectively, “Erlanger”). This procedural development may signal the potential for significant penalties for Erlanger, which was the subject of a 2005 enforcement action for similar offenses. The current lawsuit serves as a warning for hospital systems across the country regarding the legal perils of structuring physician compensation around the revenue those physicians generate through referrals.
Background
In July 2024, the United States Department of Justice intervened in a qui tam lawsuit against Erlanger. The case, originally filed in August 2021 by two former senior executives of the health system, alleges that Erlanger knowingly submitted false claims to Medicare and other federal healthcare programs by paying employed and non-employed physicians compensation that exceeded fair market value (FMV) in violation of the federal physician self-referral law, commonly known as the Stark Law.
The Erlanger Growth Strategy
The Erlanger Health System is a public, tax-exempt hospital authority that operates several hospitals in southeastern Tennessee, north Georgia, and western North Carolina. In April 2013, Erlanger hired a new CEO to reverse its financial trajectory after sustaining substantial losses in the previous two-year period. The new CEO’s strategy was straightforward: employ more physicians, particularly specialists who had been practicing at competing hospitals, and capture their patient referrals and the associated “downstream revenue” in the form of hospital facility fees for inpatient and outpatient services.
The strategy was effective. The number of physicians employed by Erlanger grew from approximately 140 in 2014 to 380 in 2018, and Erlanger’s financial position improved markedly. Erlanger publicly credited its turnaround to hiring physicians who brought increased referrals and an existing patient base. But according to the government, the growth came at a steep legal cost.
Dismantling Compliance Controls
The complaint alleges that to facilitate rapid physician hiring and retention, Erlanger systematically relaxed or eliminated the compliance controls that had been established under a prior Corporate Integrity Agreement (CIA) with HHS-OIG. Erlanger entered into that CIA in 2005 after paying $40 million to settle a prior False Claims Act (FCA) case involving Stark Law violations, the same type of misconduct now alleged in the current suit.
Under the CIA, the Chief Compliance Officer (CCO) was required to review every proposed physician contract, along with documentation of FMV and the need for the hire. After the CIA expired in 2010, compliance controls were effectively eliminated. The CCO was reduced to a non-voting member of the physician contracting committee, and the CEO began signing physician contracts before any compliance review, or over the CCO’s objections. By summer 2019, Erlanger instructed its physicians to stop bringing compliance concerns to the CCO, and in October 2019, Erlanger eliminated the role entirely.
Physician Compensation That Exceeded FMV in Violation of the Stark Law
At the heart of the lawsuit is the allegation that Erlanger designed physician compensation packages around the value of downstream referrals rather than the FMV of the physician’s personally performed services, as required under the Stark Law. Erlanger’s model included several components that the government contends inflated compensation beyond lawful levels:
- Medical director and academic salaries that were paid without requiring physicians to document time spent on administrative or academic duties or otherwise verifying that the work was actually performed.
- Uncapped productivity incentives tied to work relative value units (wRVUs) that paid escalating per-unit rates as volume increased, a structure the relators describe as “unusual and perverse” because the per-wRVU rate rose rather than fell as volume grew.
- Sign-on, retention, and program bonuses that provided additional compensation to revenue-generating physicians.
- Indirect payments routed through the University of Tennessee College of Medicine (UTCOM) purportedly for supervision of residents, where Erlanger dictated how much UTCOM should pay specific physicians.
The results were striking. Some Erlanger physicians were paid two to three times the national median salary for their specialty. By way of example, in 2017, an orthopedic surgeon received over $2.1 million (more than 3.5 times the median) and was later identified as the highest-paid orthopedic ankle physician in the nation. An electrophysiologist received over $1.6 million in 2018, more than three times the comparable median. As pled in the complaint, an income statement for all of the employed physician practices for fiscal year 2018 showed over $100 million in losses from employed physicians’ compensation compared to the revenue generated from their professional services.
Critically, the government alleged that Erlanger knew the physicians’ compensation levels exceeded FMV. Outside consultants warned Erlanger that projected compensation for certain physicians exceeded the 90th percentile of national data, that exceptionally high wRVUs raised risks of upcoding or unnecessary services, and that FMV conclusions were conditioned on documentation requirements Erlanger never enforced.
The “Leakage” Enforcement Mechanism
As pled in the complaint, Erlanger not only ignored these warnings, but actively enforced a closed referral loop to prevent “leakage” from the hospital system. Erlanger’s CEO required employed physicians to refer patients within the system and tracked compliance through “leakage reports” that identified physicians referring outside of Erlanger. Physicians who failed to keep referrals internal were reprimanded, and the CEO at times threatened adverse action, such as reduced departmental funding, against those who did not increase internal referrals. This enforcement continued under the successor CEO’s tenure, through a formal “leakage committee.”
Legal Claims and Procedural Posture
The government’s complaint in intervention asserts four causes of action:
(1) presenting false claims under 31 U.S.C. § 3729(a)(1)(A);
(2) making false statements material to false claims under § 3729(a)(1)(B);
(3) unjust enrichment; and
(4) payment by mistake.
The government alleges that Medicare paid Erlanger approximately $27.8 million for claims submitted for hospital services referred by physicians whose compensation exceeded FMV. The relators’ separate complaint also alleges violations of the Anti-Kickback Statute in connection with payments to non-employed “community physicians” and physician groups.
Erlanger moved to dismiss the government’s complaint, arguing that the broader allegations about unidentified additional physicians were insufficiently pleaded under Rule 9(b). The court denied the motion, holding that the government’s ten representative examples of false claims, naming six physicians, were sufficient to support the broader scheme alleged in the complaint. The government may now seek discovery pertaining to all physician employment agreements for which claims were submitted to Medicare during the relevant time period. Given the hundreds of physicians employed by Erlanger, the potential exposure could far exceed the $27.8 million paid by Medicare for the six sample physicians identified in the complaint. Notably, that figure does not include civil monetary penalties or treble damages permitted under the FCA.
Implications for Other Hospital Systems
The Erlanger lawsuit carries significant lessons for hospital systems that employ physicians or maintain financial relationships with referring providers.
- FMV must be reflected in actual compensation, not just in contract terms. One of the most pointed allegations in the complaint is that Erlanger’s FMV analyses addressed only projected or contractual compensation, not what Erlanger actually paid physicians. FMV assessments must account for total compensation actually paid, including all bonuses, incentives, and indirect payments.
- Downstream revenue cannot justify above-market compensation. Erlanger’s leadership repeatedly dismissed concerns about high physician pay by pointing to the profitable downstream revenue those physicians generated through referrals. Under the Stark Law, however, compensation must be consistent with FMV for the physician’s personally performed services and must not be determined in a manner that takes into account the volume or value of referrals. Hospital systems that justify physician pay based on referral value are building their compensation model on a legally impermissible foundation.
- Compliance infrastructure must be independent and empowered. The complaint describes a compliance function that was progressively marginalized from a voting, pre-approval role during the CIA period to a sidelined, non-voting role under the then-CEO, and ultimately eliminated altogether. To be effective, compliance personnel must have genuine authority, direct access to the board, and the ability to engage independent consultants without management interference.
- Escalating per-wRVU incentive structures invite scrutiny. The complaint specifically targets Erlanger’s model of paying escalating rates per wRVU as volume increased, despite being inconsistent with normal market behavior. When deploying these types of incentive structures, hospital systems must evaluate whether the resulting compensation remains within FMV at all production levels.
- Prior enforcement history raises the bar. Erlanger had already settled a Stark Law case for $40 million in 2005 and operated under a CIA for five years. The government’s complaint extensively catalogs Erlanger’s knowing violations, as well as the prior enforcement actions against other hospital systems to establish that the legal landscape was well known. Hospital systems with prior compliance histories should be especially vigilant, as regulators and courts are likely to issue more severe penalties for subsequent violations.
Conclusion
The Erlanger case is not an outlier. It is the latest in a long line of DOJ enforcement actions targeting hospital systems that pay physicians in excess of FMV to secure referrals. What makes the case particularly instructive is the granularity with which the complaint documents how a hospital system’s growth strategy (from hiring decisions driven by referral pro formas to compensation packages inflated by unsupported administrative salaries and escalating productivity bonuses) can create systemic Stark Law exposure. The takeaway from the Erlanger lawsuit and similar cases and enforcement actions is clear: downstream revenue cannot lawfully be the engine that drives a health system’s physician compensation arrangements.
How Frier Levitt Can Help
Frier Levitt regularly advises healthcare providers, hospitals, and health systems on the complex federal and state laws designed to prevent, identify, and prosecute fraud, waste, and abuse. Our attorneys assist clients in evaluating physician compensation arrangements, assessing FMV compliance, and structuring relationships to mitigate Stark Law and False Claims Act risk. If you have questions about an existing compensation model or are considering a new arrangement, contact Frier Levitt to discuss how we can help you evaluate potential exposure and implement compliant solutions.
Co-Managing Partner
Senior Counsel
